decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
National_Coverage_Determinations_Manual / 220.6.1
Subscribe or sign in to view the full article.
Article Overview
This page presents Medicare National Coverage Determination guidance for PET imaging of heart perfusion under specific clinical circumstances. It is relevant to coders, billing staff, and compliance teams working with cardiovascular nuclear medicine and PET claims. The article covers effective dates, the radiopharmaceutical categories addressed, coverage conditions tied to prior cardiac testing, and claim-submission context for earlier service dates.
Why This Topic Matters
It helps determine whether a cardiac PET perfusion study falls within Medicare coverage guidance and what general claim-processing context applies for the periods discussed.
Article Sections
-
Rubidium 82
Coverage guidance for cardiac PET perfusion imaging using one radiopharmaceutical category, including the effective date and the general clinical circumstances addressed in the policy. The section also discusses claim-submission context for an earlier period.
-
Ammonia N-13
Coverage guidance for cardiac PET perfusion imaging using a second radiopharmaceutical category, including the effective date and the general clinical circumstances addressed in the policy.
What You Will Learn
- The scope of Medicare coverage guidance for PET perfusion imaging of the heart
- Which radiopharmaceutical categories are addressed in the policy
- The effective dates associated with the coverage sections
- The general claim-submission context discussed for earlier service periods
- How the article is organized within the National Coverage Determinations Manual
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle teams
- Compliance professionals
- Nuclear medicine practices
- Cardiology practices
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com